|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/496 | |||
| A61K 31/517 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3193851 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15771461.9 |
| Europos patento paraiškos padavimo data | 2015-09-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/051030 |
| Data | 2015-09-18 |
| (87) | Numeris | WO 2016/044772 |
| Data | 2016-03-24 |
| (30) | Numeris | Data | Šalis |
| 201462052332 P | 2014-09-18 | US | |
| 201562195633 P | 2015-07-22 | US |
| (72) |
JANES, Matthew, Robert, US
PATRICELLI, Matthew, Peter, US
LI, Liansheng, US
REN, Pingda, US
LIU, Yi, US
|
| (73) |
Araxes Pharma LLC,
3033 Science Park Road, Suite 220, San Diego, CA 92121,
US
|
| (54) | COMBINATION THERAPIES FOR TREATMENT OF CANCER |
| COMBINATION THERAPIES FOR TREATMENT OF CANCER |